Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Accelera Innovations, Inc. stock logo
ACNV
Accelera Innovations
$0.00
$0.00
$0.00
N/AN/AN/AN/A
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
$0.00
$0.00
$0.00
$0.03
$5K0.9517,389 shs750 shs
SLHGF
Skylight Health Group
$0.00
$0.00
$0.00
$4K-0.378,707 shsN/A
UPHL
UpHealth
$0.00
$0.00
$0.00
$0.49
$4K0.857,364 shs5,209 shs
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Accelera Innovations, Inc. stock logo
ACNV
Accelera Innovations
0.00%0.00%0.00%0.00%0.00%
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
0.00%0.00%0.00%-75.00%-98.96%
SLHGF
Skylight Health Group
0.00%0.00%0.00%0.00%0.00%
UPHL
UpHealth
0.00%0.00%0.00%0.00%-99.95%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Accelera Innovations, Inc. stock logo
ACNV
Accelera Innovations
N/AN/AN/AN/AN/AN/AN/AN/A
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
SLHGF
Skylight Health Group
N/AN/AN/AN/AN/AN/AN/AN/A
UPHL
UpHealth
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Accelera Innovations, Inc. stock logo
ACNV
Accelera Innovations
0.00
N/AN/AN/A
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
0.00
N/AN/AN/A
SLHGF
Skylight Health Group
0.00
N/AN/AN/A
UPHL
UpHealth
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Accelera Innovations, Inc. stock logo
ACNV
Accelera Innovations
N/AN/AN/AN/AN/AN/A
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
N/AN/AN/AN/AN/AN/A
SLHGF
Skylight Health Group
$21.67M0.00N/AN/AN/ANaN
UPHL
UpHealth
$130M0.00N/AN/A$3.10 per share0.00
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Accelera Innovations, Inc. stock logo
ACNV
Accelera Innovations
N/AN/A0.00N/AN/AN/AN/AN/AN/A
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
-$39.76MN/A0.00N/AN/AN/AN/A7/21/2025 (Estimated)
SLHGF
Skylight Health Group
-$10.97MN/A0.00N/AN/AN/AN/AN/AN/A
UPHL
UpHealth
-$56.42M-$1.35N/AN/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Accelera Innovations, Inc. stock logo
ACNV
Accelera Innovations
N/AN/AN/AN/AN/A
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
N/AN/AN/AN/AN/A
SLHGF
Skylight Health Group
N/AN/AN/AN/AN/A
UPHL
UpHealth
N/AN/AN/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Accelera Innovations, Inc. stock logo
ACNV
Accelera Innovations
N/A
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
34.00%
SLHGF
Skylight Health Group
N/A
UPHL
UpHealth
56.10%

Insider Ownership

CompanyInsider Ownership
Accelera Innovations, Inc. stock logo
ACNV
Accelera Innovations
N/A
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
51.40%
SLHGF
Skylight Health Group
11.57%
UPHL
UpHealth
34.24%
CompanyEmployeesShares OutstandingFree FloatOptionable
Accelera Innovations, Inc. stock logo
ACNV
Accelera Innovations
4N/AN/ANot Optionable
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
4049.86 million24.23 millionOptionable
SLHGF
Skylight Health Group
26041.24 million36.47 millionNot Optionable
UPHL
UpHealth
1,75018.93 million12.45 millionNo Data

Recent News About These Companies

Lemon Dump Cake Recipe
DJUSIV Dow Jones US Business Support Services Index
UpHealth Inc Ordinary Shares UPHL
UpHealth, Inc. (UPHL)
Accelera Innovations stock logo

Accelera Innovations OTCMKTS:ACNV

Accelera Innovations, Inc., a healthcare service company, focuses on the development of Internet-based software in the United States. The company's Accelera Technology, an Internet-based software platform enhances the functionality and performance of healthcare services through making clinical healthcare data available to healthcare consumers. It also provides billing, practice management, and administrative services to doctors and other clinicians, as well as home health services to patients in Chicago. The company was formerly known as Accelerated Acquisitions IV, Inc. and changed its name to Accelera Innovations, Inc. in October 2011. Accelera Innovations, Inc. was founded in 2008 and is based in Colorado Springs, Colorado.

Better Therapeutics stock logo

Better Therapeutics NASDAQ:BTTX

$0.0001 0.00 (0.00%)
As of 06/25/2025 09:30 AM Eastern

Better Therapeutics, Inc., a prescription digital therapeutics company, develops a form of cognitive behavioral therapy to address the causes of cardiometabolic diseases. The company's lead product candidate is BT-001, an investigational PDT platform to treat type 2 diabetes. It also develops software-based prescription digital therapeutics platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions. In addition, the company's clinical development candidates are intended to treat cardiometabolic diseases, including type 2 diabetes, hypertension, hyperlipidemia, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, and chronic kidney disease. Its product pipeline also includes BT-002, which intends glycemic control for hypertension; BT-003 to reduce LDL cholesterol in patients with hyperlipidemia; and BT-004, which intends to explore the impact of treatment on liver health in patients with non-alcoholic steatohepatitis/non-alcoholic fatty liver disease. The company was founded in 2015 and is headquartered in San Francisco, California.

Skylight Health Group OTCMKTS:SLHGF

Skylight Health Group Inc. operates as a healthcare services and technology company in the United States. The company operates the US multi-state primary care health network, which provides a range of services from primary and urgent care, sub-specialty, allied health and wellness, and laboratory/diagnostic testing. It also provides healthcare services for older and disabled patients. The company was formerly known as CB2 Insights Inc. and changed its name to Skylight Health Group Inc. in November 2020. Skylight Health Group Inc. was founded in 2014 and is headquartered in Mississauga, Canada.

UpHealth NYSE:UPHL

$0.0002 0.00 (0.00%)
As of 06/26/2025 02:07 PM Eastern

UpHealth, Inc. provides behavioral health solutions through the utilization of evidence-based treatments and services in the Americas. The company offers mental health and substance use disorder treatment services directly to consumers. It also provides detoxification, residential, partial hospitalization program, intensive outpatient program, outpatient services, and non-clinical recovery residence and supporting housing services. UpHealth, Inc. is headquartered in Delray Beach, Florida.